Key Takeaways

• Perimenopause is a normal hormonal transition, not a problem to be fixed. Tracking hormone patterns may help women recognize changes earlier, especially during the ages of 35–45 when fertility, postpartum recovery, and early perimenopause can overlap.

• Your personal hormone baseline may be more informative than a single isolated result. Tracking several cycles can help distinguish a temporary fluctuation from a consistent change in hormone patterns.

• Mira tracks multiple reproductive hormone markers in urine, including FSH, LH, and estrogen and progesterone metabolites, allowing women and providers to see how hormones move together across the menstrual cycle.

• Urine hormone tracking and blood testing provide different kinds of information. The article describes serum testing as a “still photo” and cycle tracking as a “movie”—one captures a moment, while the other reveals patterns over time.

• Hormone information can remain valuable beyond fertility. Ovarian hormones interact with systems involving the brain, bones, gut, immune system, and cardiovascular health, making hormone awareness relevant through perimenopause and beyond.

Hormone tracking during perimenopause can help women identify changes in their individual hormone patterns over time rather than relying only on a single lab result. Mira tracks urinary markers including FSH, LH, and estrogen and progesterone metabolites, providing a cycle-wide view of hormone fluctuations. The article describes urine tracking as complementary to blood testing: serum tests capture one point in time, while repeated tracking may reveal patterns across several cycles. This information may be useful for understanding ovulation, timing progesterone testing, postpartum cycle return, and hormonal changes during the transition toward menopause.

Perimenopause has gotten a bad rap. She’s “hormonal” has a derogatory tone, but the fact is, we are all hormonal! The years before perimenopause, the season when hormones begin to shift in subtle ways, are when our bodies are already giving clues on what they need.

Why hormone tracking at this time in life? Isn’t that for fertility? Nope! This conversation with Rose MacKenzie from MiraCare looks at hormone tracking with an eye toward long-term health.

Perimenopause Is Part of the Hormonal Continuum

First and foremost, let’s change the narrative of perimenopause. It’s not a problem to be fixed; it's a normal life transition. Yet if we aren’t in good health, symptoms of perimenopause can feel like hormonal hell.

Rose suggests we think of perimenopause like “reverse puberty”. Every woman with ovaries moves through puberty. Every woman who lives long enough will also move through perimenopause and menopause. That does not mean the transition has to feel chaotic. The body gives signals. Hormone tracking can help women see those signals earlier.

This is especially important for women ages 35 to 45. Some are still trying to conceive. Some are postpartum. Some are starting to feel cycle changes. Others feel fine and simply want to prepare for the next phase with better information.

Why Your Baseline Matters

Hormone tracking becomes more useful when you’ve determined your baseline.

A single result can be helpful. A pattern tells a better story. When a woman knows what her hormones usually do, she can recognize when something has changed.

That matters because “normal” is not the same for every person. A lab value may sit inside a broad range as it still could be different from what is normal for that individual.

Rose compares this to blood pressure. One person could feel well at 120 over 80 while another person may usually run much lower. For that person, 120 over 80 could represent a real shift.

Hormones work the same way. A baseline helps patients and providers understand what is truly changing.

What MiraCare Tracks

MiraCare tracks four key reproductive hormone markers in urine. These markers are FSH, LH, and estrogen and progesterone metabolites. FSH stimulates follicles. Estrogen rises as follicles grow toward ovulation. LH triggers ovulation. Progesterone rises after ovulation and supports the luteal phase of the cycle. These hormones move in symphony with each other.

This is why tracking more than one hormone matters.

Serum Testing Still Has a Place

MiraCare does not replace blood testing. Blood testing shows what hormones are being produced. Rose describes it like a still photo; it captures one point in time.

MiraCare is more like a movie. It shows the pattern across the cycle.

Both are useful and the two approaches can support each other. A single serum result could raise a question. Cycle tracking can add context.

One Cycle Is Not the Whole Story

One unusual cycle does not always mean something is wrong.

Stress, illness, travel, medication changes, supplements, poor sleep, or a major life event can all affect hormones for a short time. A cycle may look strange and then return to the person’s usual pattern the next month.

This is why looking at more than one cycle is helpful. Several cycles can show whether a change is temporary or becoming consistent. For some people, continuous tracking feels empowering. For others, it feels stressful. The best plan depends on the patient, the provider, and the goal.

Age Is a Factor, Not the Whole Story

Many women hear a discouraging message after age 35, that their egg quality drops and fertility declines.

Yet a single person is not a statistic. Hormone tracking brings the conversation back to the individual. A woman could be 36 or 38 and still show a hormone pattern that looks similar to women who conceived successfully at a younger age.

FSH Is Dynamic

FSH has often been treated as a one-time lab value. A patient may have FSH checked on cycle day two or three. If it is high, she could be told that her fertility outlook is poor.

However, FSH is dynamic. It can shift from cycle to cycle as it could be high in one cycle and lower in the next. It can also change as the body responds to stress, inflammation, metabolic health, and targeted support.

FSH is an indicator, not an “equal sign” for fertility.

Why Day 21 Labs Can Miss the Point

Many women are told to check progesterone on cycle day 21. That only works if ovulation happened around day 14. If ovulation happens later, day 21 testing may be too early. A patient could be told that progesterone is low or that she did not ovulate. In reality, the test could simply have been done at the wrong time.

The better approach is to test seven days after ovulation. This gives a clearer view of the luteal phase.

Cycle tracking can help a patient advocate for better-timed testing.

Cortisol May Add Another Layer

MiraCare is adding cortisol tracking to its data collection. That is important for women in the fertility and pre-perimenopause window.

Cortisol is our “get up and go” hormone. When cortisol is too high for too long or elevated at the wrong time, that pattern can affect insulin. This, in turn, causes inflammation and interferes with downstream reproductive hormone signaling..

Hormones Matter Beyond Fertility

Our ovaries matter long beyond baby-making years. Estrogen and other ovarian hormones communicate with the brain, bones, gut, immune system, and cardiovascular system.

This is why hormone tracking should not stop being relevant once pregnancy is no longer the goal.

FSH may be more than a fertility marker as it also gives insight into future health risk.

Use the Data Before Your Body Has to Shout

Hormone tracking gives women a way to listen to their bodies earlier.

It can help a woman understand her fertility window. It can help a postpartum woman see when hormone cycling returns. It can also help providers make better decisions.

At Health Youniversity, we believe women deserve healthcare that listens to the body before symptoms begin to shout. Fertility, postpartum, and perimenopause are connected chapters in the same woman’s life.

If you are in the pre-perimenopause window, start with awareness. Learn your baseline. Track the pattern. Then use that information to support the body you have now and the health you want later.

Frequently Asked Questions - FAQs

What is perimenopause?

Perimenopause is the hormonal transition leading toward menopause. The article describes it as a normal stage of life and compares it to “reverse puberty,” when ovarian hormone patterns gradually begin changing.

These changes may begin subtly before someone clearly identifies themselves as being in perimenopause.

At what age should women start paying attention to perimenopause?

The article highlights ages 35 to 45 as an important window for hormone awareness. During this period, some women are still trying to conceive, some are postpartum, and others may be beginning to notice changes in their cycles or symptoms.

Why track hormones during perimenopause?

Hormone tracking can help establish a personal baseline and reveal how hormone patterns change over time.

Rather than waiting until symptoms become severe, the article suggests using data to identify changing patterns earlier and provide more context for conversations with healthcare providers.

Why is a hormone baseline important?

Every woman's hormone pattern can be different. A broad laboratory reference range does not necessarily show what is typical for a specific individual.

Knowing your usual pattern may make it easier to identify meaningful changes as you move through different hormonal stages.

What hormones does Mira track?

According to the article, Mira tracks four key reproductive hormone markers through urine:

• FSH

• LH

• Estrogen metabolites

• Progesterone metabolites

Together, these markers help show the hormonal pattern surrounding follicle development, ovulation, and the luteal phase.

What does FSH tell you?

FSH, or follicle-stimulating hormone, helps stimulate follicle development.

The article emphasizes that FSH is dynamic rather than fixed. It can vary from one cycle to another, so a single high result should be viewed as one piece of information rather than an “equal sign” for fertility.

What does LH tell you?

LH, or luteinizing hormone, plays an important role in triggering ovulation. Tracking LH alongside other hormone markers may help provide context for when ovulation is occurring.

Why track estrogen and progesterone too?

Estrogen generally rises as follicles grow toward ovulation, while progesterone rises after ovulation and supports the luteal phase.

Because reproductive hormones interact with one another, the article argues that tracking multiple markers can provide a more complete picture than looking at only one hormone.

Does Mira replace hormone blood tests?

No. The article specifically states that Mira does not replace serum testing.

Blood testing and urine tracking provide different information. Serum testing is compared to a still photograph of hormones at one point in time, while repeated tracking is compared to a movie that shows patterns across the cycle.

How many cycles should I track?

The article does not provide one required number for everyone. It emphasizes that one unusual cycle may be influenced by stress, illness, travel, medications, supplements, poor sleep, or major life events.

Tracking across several cycles may help determine whether a pattern is temporary or becoming consistent.

Can stress change hormone tracking results?

Yes. The article notes that stress, illness, sleep disruption, travel, medication changes, supplements, and major life events may temporarily influence hormone patterns.

This is another reason not to interpret one unusual cycle in isolation.

Why can a day-21 progesterone test be misleading?

A day-21 progesterone test assumes that ovulation occurred around day 14.

If a woman ovulates later, day 21 may be too early to accurately evaluate her luteal-phase progesterone. The article recommends thinking in terms of testing approximately seven days after ovulation instead of automatically using cycle day 21.

Can hormone tracking help time progesterone bloodwork?

According to the article, yes. If tracking helps identify when ovulation actually occurred, that information can help a patient and provider choose a more appropriate time for luteal-phase testing.

Does fertility always decline dramatically after age 35?

The article cautions against treating age statistics as an individual diagnosis. Age is an important factor, but it is not the entire fertility picture.

Hormone patterns and other individual health information can provide additional context for women in their mid-to-late 30s.

Is FSH always high once perimenopause begins?

The article describes FSH as a dynamic marker that can change from cycle to cycle. A single measurement may therefore not tell the entire story.

Looking at patterns over time may provide more context than interpreting one isolated value.

Can hormone tracking be useful postpartum?

Yes. Rose MacKenzie has experience using hormone monitoring in postpartum amenorrhea, and the article notes that tracking may help women observe when hormone cycling begins returning after pregnancy.

Can hormone tracking be useful if I'm no longer trying to conceive?

Yes. One of the main themes of the article is that reproductive hormones remain relevant beyond fertility.

Ovarian hormones communicate with systems involving the brain, bones, gut, immune system, and cardiovascular health, so hormone awareness may still have value during perimenopause and later life.

What role might cortisol play during perimenopause?

The article notes that Mira is adding cortisol tracking to its data collection. Cortisol is described as a “get up and go” hormone that may affect insulin and downstream reproductive hormone signaling when it remains elevated or is elevated at inappropriate times.

Can continuous hormone tracking become stressful?

For some people, yes. The article acknowledges that continuous tracking can feel empowering for some women and stressful for others.

The appropriate amount of tracking should depend on the individual's goals, preferences, and provider guidance.

Check out all of our episodes on the following platforms:

YouTube

Apple Podcasts

Spotify

Buzzsprout

As the Clinical Manager at Mira, Rose MacKenzie assists healthcare professionals and providers in successfully using Mira with their patients. With over 10 years of experience in natural family planning, Rose has extensive experience assisting women using the Mira monitor for hormone monitoring and health promotion, including women tracking their hormones in regular cycles, irregular cycles, postpartum amenorrhea, chemo-induced menopause, and perimenopause.

Mira is a medical device quality hormone 4 hormone tracker that uses fluorescent technology to achieve sensitive changes to hormone fluctuation

MIRA: https://www.miracare.com/

Medical Disclaimer:

By listening to the Health Youniversity podcast, you agree not to use this podcast as medical advice to treat any medical condition for yourself or others. Consult your healthcare provider for any medical issues you may have. This entire disclaimer also pertains to any guests or contributors to any Health Youniversity podcast.